European Archives - Page 698 of 1226 - European Medical Journal

EMJ 6.1 Feature Image

Rare 2030 Final Policy Conference: Summary of the Recommendations of the Rare 2030 Foresight Study

IMPROVING the lives of people living with a rare disease in Europe has been an overarching aim of the Rare 2030 Foresight Study, a two-year study…

Performance of Different Criteria Sets for Inflammatory Back Pain in Radiographic

It is important to recognise inflammatory back pain (IBP) for early diagnosis of ankylosing spondylitis (AS). The aims of this study were to develop….

Can Blocking Nef Proteins Treat Immunodeficiency in HIV?

IMMUNODEFIENCY in patients with HIV may be counteracted by drugs that block protein kinases, according to a new study carried out by researchers at the…

Advanced CAR T-Cell Therapy for Multiple Myeloma

PROMISING results of a newly advanced chimeric antigen receptor (CAR) T-cell therapy showed that more than triple the period remission for multiple myeloma.

An Interview with Major (Retd) Sally Orange

Sally Orange, | Physiotherapist | Endurance Runner | Mental Health Champion

EMJ Podcast: Decisions, Development, and Devices

Dr. Brian Dunkin, Chief Medical Officer, Boston Scientific, explores the advancements in minimally invasive surgery, reflects on the growth of telemedicine, and considers the science behind recruitment and embedding culture within organisations.

Talking to José Maria Guido Avila

José Maria Guido Avila, Global Lead HCP Marketing, Sanofi, shares his thoughts on appropriate metrics measure the success of virtual events.

Can Triptonide Function as a Nonhormonal Male Contraceptive?

TRIPTONIDE, a natural compound which can either be purified from the Chinese Tripterygium wilfordii Hook F herb or produced through chemical synthesis…

Human Embryo Research Beyond the 14-day Limit

SINCE the successful birth of the world’s first in vitro fertilisation baby in 1978, in vitro culture of human embryos for research and assisted…

The Dog Detectives Catching Prostate Cancer

DOGS have the ability to detect aggressive prostate cancer from urine samples, new research reports. The pilot study was carried out by Medical Detection Dogs, Great Horwood, Milton Keynes, UK, a nonprofit organisation that carries out research on early disease diagnosis as well as training dogs to support people with complex and life-threatening medical conditions.